Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler

PHASE3TerminatedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

March 31, 2012

Conditions
Type 2 Diabetes
Interventions
DRUG

Technosphere® Insulin Inhalation Powder

DRUG

Insulin Aspart

Usual Care

DRUG

Insulin Glargine

Trial Locations (29)

11042

North Shore Diabetes and Endocrine Associates, New Hyde Park

11501

Winthrop University Hospital, Mineola

27834

Endocrine Research Physicians East PA, Greenville

30308

Laureate Clinical Research Group, Atlanta

30309

Atlanta Diabetes Associates, Atlanta

30338

Alta Pharmaceutical Research Center, Dunwoody

36608

Coastal Clinical Research Inc, Mobile

38119

The Endocrine Clinic, Memphis

44060

Your Diabetes Endocrine Nutrition Group, Inc., Mentor

46360

LaPorte County Institute for Clinical Research Inc., Michigan City

55435

Radiant Research Inc (Minneapolis), Edina

59101

Billings Clinic Research Center, Billings

60612

John H Stoger Jr Hospital of Cook County, Chicago

63110

Washington University School of Medicine, St Louis

63376

Amin Radparvar's Private Practice, City of Saint Peters

68131

Creighton Diabetes Center, Omaha

75230

Dallas Diabetes & Endocrine Center, Dallas

75246

Baylor Endocrine Center, Dallas

75390

University of Texas Southwestern Medical Center, Dallas

78229

SAM Clinical Research Center, San Antonio

84044

Exodus Healthcare Network, Magna

87131

University of New Mexico HCS, Albuquerque

90806

Health Care Partners Medical Group, Long Beach

92780

Diabetes Research Center, Tustin

93720

Valley Research, Fresno

94598

Diablo Clinical Research, Walnut Creek

97232

Legacy Clinical Research, Portland

97239

OHSU Diabetes Center Research Oregon Health & Science University, Portland

05403

Diabetes Research Center -Fletcher Allen Health Care, South Burlington

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY